Skip to content
10-K

Annual Report

THC THERAPEUTICS, INC.

0001477932-24-000896

← back to feed
Filed
Feb 26, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Feb 26, 2024 34.15M sh
Stock Repurchased FY 2023 · Jul 31, 2023 $0
Stock Repurchased FY 2023 · Jul 31, 2022 $97.5K
Operating Cash Flow FY 2023 · Jul 31, 2022 −$418.92K
Current Liabilities FY 2023 · Jul 31, 2022 $3.22M
Total Liabilities FY 2023 · Jul 31, 2022 $3.22M
Current Assets FY 2023 · Jul 31, 2022 $40.71K
Total Assets FY 2023 · Jul 31, 2022 $206.9K
Net Income FY 2023 · Jul 31, 2022 −$1.52M
Operating Income FY 2023 · Jul 31, 2022 −$1.75M
Gross Profit FY 2023 · Jul 31, 2022 $0
Cost Of Revenue FY 2023 · Jul 31, 2022 $0
Revenue FY 2023 · Jul 31, 2022 $0
Stockholders Equity FY 2023 · Jul 31, 2021 −$2.48M